Parkinson's disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing neurons in a specific area of the brain called substantia nigra. It is a complex disease that requires healthcare professionals to have a comprehensive understanding for effective management.
PD affects approximately 1% of individuals aged 60 years and above, with men being 1.5 times more likely to have the disease than women. The major risk factors include age, genetic predisposition, and exposure to certain environmental factors such as pesticides.
PD is primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a decrease in striatal dopamine levels. This imbalance in the basal ganglia circuitry results in motor and non-motor symptoms associated with PD.
PD typically presents with motor symptoms such as bradykinesia, rigidity, rest tremor, and postural instability. Non-motor symptoms, including cognitive impairment, mood disorders, autonomic dysfunction, and sleep disturbances, can also significantly impact the quality of life of PD patients.
Diagnosis of PD is primarily clinical, based on history and neurological examination. Neuroimaging and biomarkers can support the diagnosis but are not definitive. Management of PD is symptomatic, focusing on improving quality of life. Pharmacological interventions primarily aim to restore dopamine levels, while non-pharmacological interventions include physical therapy and lifestyle modifications.
Understanding PD's complexities is crucial for healthcare professionals to provide optimal patient care. Continued research into the pathophysiology, risk factors, and potential therapies is essential to improve the prognosis and quality of life of individuals with PD.
1.
Advancing Health in Africa
2.
Financial hardship common in patients with cancer
3.
Immunotherapy Is As Safe As Other Cancer Treatments During Pregnancy.
4.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
5.
New study links air pollution with higher rates of head and neck cancer
1.
Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches
2.
Care Planning for Chronic Blood Disorders
3.
Circulating Tumor DNA in Early Cancer Detection
4.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
5.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Understanding the Role of Screening in Cancer Prevention
3.
Innovations in Hematology
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Understanding the Importance of Follow-Up After Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation